Sativex
Sativex® is a cannabinoid medicine for the treatment of spasticity due to multiple sclerosis which is also in development in cancer pain and neuropathic pain of various origins...
Sativex® has now been launched in 11 countries (including the UK, Spain, Italy and Germany) and approved in a further 13 (map below)
Please note that we cannot provide advice on the suitability of Sativex for individual patients.
Patients wishing to know more about Sativex should discuss with their doctor the most suitable treatment for them.
